AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that Arthur M. Krieg, M.D., has joined the Company as a Scientific Advisor. “We are very pleased about the addition of Dr. Krieg to our team of outstanding Scientific Advisors. Dr. Krieg brings extensive scientific, discovery, and early-stage product development expertise in oligonucleotide therapeutics to Mirna, which will help us craft our research and development plans for the years ahead,” said Dr. Paul Lammers, President and Chief Executive Officer of Mirna Therapeutics.
